• Profile
Close

EUS-guided vs percutaneous gallbladder drainage: Isn’t it time to convert?

Journal of Clinical Gastroenterology Dec 19, 2017

Tyberg A, et al. - This study reports a multicenter, international experience comparing endoscopic ultrasound–guided drainage (EUS-GLB) and percutaneous drainage (PC-GLB) in nonsurgical patients with cholecystitis. As per the data, technical and clinical success rates afforded by EUS-GLB were comparable to those of PC-GLB and there was no difference in adverse events associated with both of these approaches. Notably, EUS-GLB displayed safety and efficacy and afforded a decreased number of repeat interventions, thereby, offering a potential cost-saving benefit and morbidity benefit.

Methods

  • This study was performed on all patients who underwent either PC-GLB drainage or EUS-GLB drainage from 7 centers between January 2010 and December 2015.
  • Successful placement of a catheter or stent into the gallbladder defined technical success, and clinical success was defined as resolution of clinical symptoms after intervention.
  • For all patients, adverse events, length of stay, and the requirement for repeat interventions and/or hospitalizations were recorded.

Results

  • This study included a total of 155 patients (mean age 74±14.24 y; range, 31 to 96; 56% male).
  • EUS-GLB and PC-GLB were performed on 42 patients and 113 patients, respectively.
  • Findings demonstrated that technical success was achieved in 40 patients (95%) in the EUS-GLB group and 112 patients (99%) in the PC-GLB group (P=0.179) and clinical success was achieved in 40 patients (95%) in the EUS-GLB group and 97 patients (86%) in the PC-GLB group (P=0.157).
  • Researchers found no difference in hospital readmission rates between the 2 groups (14% vs. 24%; P=0.194).
  • However, they noted that PC-GLB group (n=28, 24%) included significantly higher number of patients requiring repeat interventions compared with the EUS-GLB group (n=4, 10%) (P=0.037).
  • Between the 2 groups, no difference was reported in adverse events.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay